Revenue Recognition (Tables)

9 Months Ended

Sep. 30, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table presents disaggregated revenue by major product and service categories:

(in thousands)	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2023		2022		2023		2022
CAG segment revenue:
CAG Diagnostics recurring revenue:	$	733,958	$	667,309	$	2,223,336	$	2,017,532
IDEXX VetLab consumables	296,042		262,820		890,891		796,072
Rapid assay products	87,562		80,542		266,934		242,542
Reference laboratory diagnostic and consulting services	320,294		295,590		973,580		894,795
CAG Diagnostics services and accessories	30,060		28,357		91,931		84,123
CAG Diagnostics capital - instruments	32,254		35,176		99,452		108,400
Veterinary software, services and diagnostic imaging systems	70,948		62,505		208,303		184,329
CAG segment revenue	837,160		764,990		2,531,091		2,310,261
Water segment revenue	44,450		40,840		126,362		116,406
LPD segment revenue	29,747		28,452		88,866		89,211
Other segment revenue	4,170		7,379		13,033		22,878
Total revenue	$	915,527	$	841,661	$	2,759,352	$	2,538,756

Revenue by principal geographic area, based on customers’ domiciles, was as follows:

(in thousands)	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2023		2022		2023		2022
United States	$	603,046	$	560,292	$	1,815,066	$	1,646,023
Europe, the Middle East and Africa	177,852		152,235		532,526		488,036
Asia Pacific Region	77,666		76,799		236,932		240,760
Canada	35,612		33,642		113,209		108,407
Latin America & Caribbean	21,351		18,693		61,619		55,530
Total revenue	$	915,527	$	841,661	$	2,759,352	$	2,538,756